EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells

Sergey E Parfenyev, Sergey V Shabelnikov, Elena N Tolkunova iD, Nickolai A Barlev, Alexey G Mittenberg iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24129806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sergey E Parfenyev und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia. Hauptthemen laut MEDLINE: Zinc Finger E-box-Binding Homeobox 1, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Foundation for Basic Research, Ministry of Science and Higher Education of the Russian Federation, Nazarbayev University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P53 is a critical tumor suppressor that protects the integrity of genome and prevents cells from malignant transformation, including metastases. One of the driving forces behind the onset of metastases is the epithelial to mesenchymal transition (EMT) program. Zeb1 is one of the key transcription factors that govern EMT (TF-EMT). Therefore, the interaction and mutual influence of p53 and Zeb1 plays a critical role in carcinogenesis. Another important feature of tumors is their heterogeneity mediated by the presence of so-called cancer stem cells (CSCs). To this end, we have developed a novel fluorescent reporter-based approach to enrich the population of CSCs in MCF7 cells with inducible expression of Zeb1. Using these engineered cell lines, we studied the effect of p53 on Zeb1 interactomes isolated from both CSCs and regular cancer cells. By employing co-immunoprecipitations followed by mass spectrometry, we found that the composition of Zeb1 interactome was affected not only by the p53 status but also by the level of Oct4/Sox2 expression, indicating that stemness likely affects the specificity of Zeb1 interactions. This study, together with other proteomic studies of TF-EMT interactomes, provides a framework for future molecular analyses of biological functions of Zeb1 at all stages of oncogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zinc Finger E-box-Binding Homeobox 1Breast NeoplasmsHumansFemaleTumor Suppressor Protein p53Epithelial-Mesenchymal TransitionProteomicsNeoplastic Stem CellsCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Zeb1breast cancercancer stem cellsepithelial-to-mesenchymal transition (EMT)metastasisp53

Substanzen

Zinc Finger E-box-Binding Homeobox 1Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia.
  • Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Astana 20000, Kazakhstan.

ORCID-Profile: Elena N Tolkunova, Alexey G Mittenberg

Förderung

  • Russian Foundation for Basic Research
  • Ministry of Science and Higher Education of the Russian Federation
  • Nazarbayev University
  • Russian Science Foundation

Zitieren

APA

Parfenyev, S. E., Shabelnikov, S. V., Tolkunova, E. N., Barlev, N. A., & Mittenberg, A. G. (2023). p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24129806

Vancouver

Parfenyev SE, Shabelnikov SV, Tolkunova EN, Barlev NA, Mittenberg AG. p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24129806

BibTeX
@article{Parfenyev2023,
  author = {Parfenyev, Sergey E and Shabelnikov, Sergey V and Tolkunova, Elena N and Barlev, Nickolai A and Mittenberg, Alexey G},
  title = {p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24129806}
}
Kostenlos starten →